Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,18584334,mass,"PLA microsphere formulations revealed lack of cytotoxicity and a mass median aerodynamic diameter (MMDA) of 2.22-2.86 mum, while PLGA particles were larger (MMDA of 4.67-5.11 mum).",Slow release formulations of inhaled rifampin. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/18584334/),mum,2.22-2.86,66349,DB01442,MMDA
,18584334,aerodynamic diameter (MMDA),"PLA microsphere formulations revealed lack of cytotoxicity and a mass median aerodynamic diameter (MMDA) of 2.22-2.86 mum, while PLGA particles were larger (MMDA of 4.67-5.11 mum).",Slow release formulations of inhaled rifampin. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/18584334/),mum,2.22-2.86,66350,DB01442,MMDA
,18584334,M,"PLA microsphere formulations revealed lack of cytotoxicity and a mass median aerodynamic diameter (MMDA) of 2.22-2.86 mum, while PLGA particles were larger (MMDA of 4.67-5.11 mum).",Slow release formulations of inhaled rifampin. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/18584334/),mum,4.67-5.11,66351,DB01442,MMDA
,18584334,t (max),Pharmacokinetics differed among the formulations with the 10% PLA formulation showing a distinct sustained release (t (max) of 2 h vs 0.5 h of free drug) and a systemic bioavailability similar to that of free drug.,Slow release formulations of inhaled rifampin. ,tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/18584334/),h,2,66352,DB01442,MMDA
,18584334,t (max),Pharmacokinetics differed among the formulations with the 10% PLA formulation showing a distinct sustained release (t (max) of 2 h vs 0.5 h of free drug) and a systemic bioavailability similar to that of free drug.,Slow release formulations of inhaled rifampin. ,tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/18584334/),h,0.5,66353,DB01442,MMDA
,18584334,relative bioavailability,Formulations with high polymer content showed a lower relative bioavailability (30%).,Slow release formulations of inhaled rifampin. ,F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/18584334/),%,30,66354,DB01442,MMDA
